About Vanderbilt University Medical Center Ventures
Vanderbilt University Medical Center Ventures is the commercialization and venture arm of VUMC in Nashville. It deploys seed capital into spinouts of proprietary medical technologies and health software developed within the institution, with a stated focus on life sciences tools and digital health. AI is not a declared investment theme.
The fund operates at pre-seed and seed, writing relatively small checks of $250K to $1M. That sizing is consistent with its mandate as an academic commercialization vehicle rather than a scale-out investor. Geographic activity centers on U.S. companies, particularly those with technology origins or clinical relationships in the VUMC ecosystem.
Founders most relevant to VUMC Ventures are typically faculty entrepreneurs, recent spinouts, or external startups that license Vanderbilt IP or run clinical work with VUMC. The realistic path includes engagement with the technology transfer office and a defined plan for early validation or clinical study at VUMC. External startups without an institutional connection should be prepared to make that linkage explicit. Limited public information is available about portfolio breadth.
Founder reviews
Other portfolio companies
Companies in Vanderbilt University Medical Center Ventures's portfolio not currently in our directory.
- Arena Therapeutics
- ImageAssist
Pitch / review this investor
Have you raised from Vanderbilt University Medical Center Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).